PEGylated interferon beta-1b (Polytherics/Nuron)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePEGylated interferon beta-1b (Polytherics/Nuron)
Drug Alias NamePEGylated NU-100 (Nuron Biotech)TheraPEG IFN beta-1b (PolyTherics)TheraPEG interferon betaPEGylated interferon beta-1b (Nuron Biotech)interferon beta-1b biobetter (Polytherics/Nuron) +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbzena Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbzena LtdNuron Biotech Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A